Jan Johansson

22.0k total citations · 3 hit papers
396 papers, 17.8k citations indexed

About

Jan Johansson is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Jan Johansson has authored 396 papers receiving a total of 17.8k indexed citations (citations by other indexed papers that have themselves been cited), including 191 papers in Molecular Biology, 95 papers in Pulmonary and Respiratory Medicine and 71 papers in Physiology. Recurrent topics in Jan Johansson's work include Neonatal Respiratory Health Research (87 papers), Alzheimer's disease research and treatments (64 papers) and Silk-based biomaterials and applications (57 papers). Jan Johansson is often cited by papers focused on Neonatal Respiratory Health Research (87 papers), Alzheimer's disease research and treatments (64 papers) and Silk-based biomaterials and applications (57 papers). Jan Johansson collaborates with scholars based in Sweden, United Kingdom and United States. Jan Johansson's co-authors include Tore Curstedt, Anna Rising, Hans Jörnvall, Johan Thyberg, Bengt Robertson, My Hedhammar, Jenny Presto, Kerstin Nordling, Birgitta Agerberth and Lars O. Tjernberg and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Jan Johansson

386 papers receiving 17.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand

1996 834 citations Jan Johansson et al. profile →
Molecular basis for amyloid fibril formation and stability

2005 551 citations Jan Johansson et al. profile →
Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37

1998 541 citations Jan Johansson et al. profile →

Peers

Countries citing papers authored by Jan Johansson

Since Specialization

Citations

This map shows the geographic impact of Jan Johansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Johansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Johansson more than expected).

Fields of papers citing papers by Jan Johansson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Johansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Johansson. The network helps show where Jan Johansson may publish in the future.

Co-authorship network of co-authors of Jan Johansson

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Johansson. A scholar is included among the top collaborators of Jan Johansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Johansson. Jan Johansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Helicobacter pylori CagA protein is a potent and broad-spectrum amyloid inhibitor 2025 ·Science Advances ·(unknown), (unknown), (unknown), Axel Leppert, Rakesh Kumar, (unknown), Lotte B. Nielsen, Olena Moshynets, M. S. Frasinyuk, (unknown), Daniel Ferreira, Axel Abelein, Michael Landreh, Stefan D. Knight, Jan Johansson, Daniel E. Otzen, Gefei Chen	0
2	Specific inhibition of α‐synuclein oligomer generation and toxicity by the chaperone domain Bri2 BRICHOS 2024 ·Protein Science ·(unknown), Rakesh Kumar, Luis Enrique Arroyo‐García, (unknown), (unknown), (unknown), Azad Farzadfard, (unknown), Janni Nielsen, Henrik Biverstål, Daniel E. Otzen, Jan Johansson, Axel Abelein	4
3	Intravenous chaperone treatment of late-stage Alzheimer´s disease (AD) mouse model affects amyloid plaque load, reactive gliosis and AD-related genes 2024 ·Translational Psychiatry ·(unknown), Makiko Ohshima, David Brodin, Yu Wang, (unknown), Marianne Schultzberg, Gefei Chen, Jan Johansson	3
4	Identification of glycolytic proteins as binding partners of Bri2 BRICHOS domain 2023 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Makoto Shimozawa, Per Nilsson, Alexey E. Lyashkov, Mohammed Khadeer, Ivar Järving, Luigi Ferrucci, (unknown), Jan Johansson, Ruin Moaddel	0
5	A new kid in the folding funnel: Molecular chaperone activities of the BRICHOS domain 2023 ·Protein Science ·Axel Leppert, (unknown), Michael Landreh, Axel Abelein, Gefei Chen, Jan Johansson	18
6	S100A9 amyloid growth and S100A9 fibril-induced impairment of gamma oscillations in area CA3 of mouse hippocampus ex vivo is prevented by Bri2 BRICHOS 2022 ·Progress in Neurobiology ·Yuniesky Andrade‐Talavera, Gefei Chen, Jonathan Pansieri, Luis Enrique Arroyo‐García, (unknown), Vytautas Smirnovas, Jan Johansson, Ludmilla A. Morozova‐Roche, André Fisahn	7
7	Large-Scale Robot-Based Polymer and Composite Additive Manufacturing: Failure Modes and Thermal Simulation 2022 ·Polymers ·Saeed Akbari, Jan Johansson, (unknown), (unknown), Seyed Hosseini	4
8	Benzimidazole‐based fluorophores for the detection of amyloid fibrils with higher sensitivity than Thioflavin‐T 2020 ·Journal of Neurochemistry ·Narayanaperumal Pravin, Rakesh Kumar, Shalini Tripathi, (unknown), Ganesh M. Mohite, Ambuja Navalkar, Rajlaxmi Panigrahi, Namrata Singh, Laxmikant Gadhe, Shaffi Manchanda, Makoto Shimozawa, Per Nilsson, Jan Johansson, Ashutosh Kumar, Samir K. Maji, Maheswaran Shanmugam	13
9	Modulation of Kv3.1/Kv3.2 promotes gamma oscillations by rescuing Aβ‐induced desynchronization of fast‐spiking interneuron firing in an AD mouse model in vitro 2020 ·The Journal of Physiology ·Yuniesky Andrade‐Talavera, Luis Enrique Arroyo‐García, Gefei Chen, Jan Johansson, André Fisahn	33
10	Amyloid-β Peptide Targeting Peptidomimetics for Prevention of Neurotoxicity 2019 ·ACS Chemical Neuroscience ·Dmytro Honcharenko, (unknown), (unknown), Jyotirmoy Maity, (unknown), Henrik Biverstål, Erik Hjorth, Jan Johansson, André Fisahn, Lennart Nilsson, Roger Strömberg	11
11	High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidogenic proteins 2017 ·The EMBO Journal ·Lisa Vincenz‐Donnelly, (unknown), Roman Körner, Erik C Hansen, Jenny Presto, Jan Johansson, Ritwick Sawarkar, F. Ulrich Hartl, Mark S. Hipp	27
12	A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers 2015 ·Nature Structural & Molecular Biology ·Samuel I. A. Cohen, Paolo Arosio, Jenny Presto, Firoz Roshan Kurudenkandy, Henrik Biverstål, (unknown), Christopher J.R. Dunning, Xiaoting Yang, Birgitta Frohm, Michele Vendruscolo, Jan Johansson, Christopher M. Dobson, André Fisahn, Tuomas P. J. Knowles, Sara Linse	351
13	RVX-208 2010 ·Journal of the American College of Cardiology ·Dana Bailey, Ravi Jahagirdar, Allan Gordon, Anouar Hafiane, (unknown), Safia Chatur, Gregory S. Wagner, Henrik C. Hansen, (unknown), Jan Johansson, Larbi Krimbou, Norman C.W. Wong, Jacques Genest	181
14	Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers 2004 ·European Journal of Biochemistry ·Didier Belorgey, (unknown), Damian C. Crowther, Maki Onda, Jan Johansson, David A. Lomas	42
15	From overeducation to underlearning : a survey of Swedish research on the interplay between education, work and learning 2004 ·KTH Publication Database DiVA (KTH Royal Institute of Technology) ·(unknown), Lena Abrahamsson, Jan Johansson	1
16	Cellular Antiendotoxin Activities of Lung Surfactant Protein C in Lipid Vesicles 2003 ·American Journal of Respiratory and Critical Care Medicine ·Luis A. Augusto, Monique Synguélakis, Quentin Espinassous, Michel Lepoivre, Jan Johansson, Richard Chaby	33
17	Qualified Vocational Education beyond 2000--A Report from a Pilot Project in Sweden. 2000 ·KTH Publication Database DiVA (KTH Royal Institute of Technology) ·Jan Johansson, (unknown), (unknown), (unknown)	2
18	Four years experience of a cardiovascular opportunistic screening and prevention programme in the primary health care in Sollentuna, Sweden 1999 ·Scandinavian Journal of Primary Health Care ·Mai‐Lis Hellénius, Jan Johansson, Ulf dé Fairé, Stig Elofsson, Ingvar Krakau	14
19	The proteins of the surfactant system 1994 ·European Respiratory Journal ·Jan Johansson, Tore Curstedt, Bengt Robertson	174
20	The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST) 1994 ·The American Journal of Cardiology ·Göran Walldius, Uno Erikson, Anders Olsson, L. Bergstrand, Karin Hådell, Jan Johansson, L. Kaijser, Claes Lassvik, Jörgen Mölgaard, Sven Nilsson, Liselotte Schäfer Elinder, G Stenport, Ingar Holme	180

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact